טוען...
Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients
BACKGROUND: β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES: We aimed to investigate the efficacy and...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Kowsar
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4102988/ https://ncbi.nlm.nih.gov/pubmed/25068055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/ircmj.18028 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|